• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素依赖型糖尿病患者对活化蛋白C的抗凝反应增强。

Enhanced anticoagulant response to activated protein C in patients with IDDM.

作者信息

Krugluger W, Kopp H P, Schernthaner G, Hopmeier P

机构信息

Department of Laboratory Medicine, Rudolfstiftung Hospital, Vienna, Austria.

出版信息

Diabetes. 1995 Sep;44(9):1033-7. doi: 10.2337/diab.44.9.1033.

DOI:10.2337/diab.44.9.1033
PMID:7657025
Abstract

Anticoagulant response to activated protein C (APC) was studied in 40 healthy subjects and 67 patients with insulin-dependent diabetes mellitus (IDDM) using a modified activated thromboplastin time assay. Results are expressed in terms of the APC sensitivity ratio (APC SR). In addition, plasma levels of protein C, total and free protein S (PS), coagulation factors V and VIII, and prothrombin fragment 1+2 (F1+2) were measured. Patients with IDDM and a urinary albumin excretion rate (UAER) < 30 mg/24 h showed a median APC SR of 2.5 (interquartile range 2.3-2.9). In patients with a UAER between 30 and 300 mg/24 h, the median APC SR was 2.7 (2.7-2.9). Both values were significantly greater than the median APC SR of 2.1 (2.0-2.5) observed in healthy control subjects (P < 0.001). Also, the percentage of subjects with an APC SR < or = 2.0 was markedly smaller in both patient groups. Factor V and VIII levels were not significantly different between IDDM patients and healthy subjects. Grouping of IDDM patients according to the APC SR revealed significantly enhanced levels of total PS (P < 0.05) and factor VIII (P < 0.01) in patients with a poor anticoagulant response to APC (APC SR < or = 2.0) compared with those with an APC SR > 2.7. The negative correlation of the APC SR in diabetic patients with both coagulation and anticoagulation factors indicates a complex role of this parameter in regulating the coagulation system in IDDM.

摘要

采用改良的活化部分凝血活酶时间测定法,对40名健康受试者和67名胰岛素依赖型糖尿病(IDDM)患者的抗凝血蛋白C(APC)反应进行了研究。结果以APC敏感性比值(APC SR)表示。此外,还检测了血浆中蛋白C、总蛋白S和游离蛋白S(PS)、凝血因子V和VIII以及凝血酶原片段1+2(F1+2)的水平。IDDM且尿白蛋白排泄率(UAER)<30 mg/24 h的患者,APC SR中位数为2.5(四分位间距2.3 - 2.9)。UAER在30至300 mg/24 h之间的患者,APC SR中位数为2.7(2.7 - 2.9)。这两个值均显著高于健康对照受试者观察到的APC SR中位数2.1(2.0 - )(P < 0.001)。此外,两个患者组中APC SR≤2.0的受试者百分比明显较小。IDDM患者和健康受试者之间的因子V和VIII水平无显著差异。根据APC SR对IDDM患者进行分组后发现,与APC SR>2.7的患者相比,对APC抗凝血反应较差(APC SR≤2.0)的患者总PS水平(P < 0.05)和因子VIII水平(P < 0.01)显著升高。糖尿病患者中APC SR与凝血因子和抗凝血因子的负相关表明该参数在调节IDDM凝血系统中起复杂作用。 (注:原文此处四分位间距括号内数字似乎有误,已按原文翻译)

相似文献

1
Enhanced anticoagulant response to activated protein C in patients with IDDM.胰岛素依赖型糖尿病患者对活化蛋白C的抗凝反应增强。
Diabetes. 1995 Sep;44(9):1033-7. doi: 10.2337/diab.44.9.1033.
2
Activated-protein-C resistance in cancer patients.癌症患者的活化蛋白C抵抗
Haemostasis. 1997 May-Jun;27(3):112-8. doi: 10.1159/000217442.
3
Haemostatic changes and acquired activated protein C resistance in normal pregnancy.正常妊娠中的止血变化与获得性活化蛋白C抵抗
Blood Coagul Fibrinolysis. 2007 Oct;18(7):685-8. doi: 10.1097/MBC.0b013e3282f09835.
4
Resistance to activated protein C: evaluation of three functional assays.对活化蛋白C的抵抗:三种功能测定法的评估
Thromb Res. 1994 Oct 1;76(1):47-59. doi: 10.1016/0049-3848(94)90206-2.
5
APC-resistance as measured by a Textarin time assay: comparison to the APTT-based method.通过泰克他林时间测定法测量的活化部分凝血活酶时间(APTT)抵抗:与基于APTT的方法的比较。
Thromb Res. 1996 Sep 1;83(5):363-73. doi: 10.1016/0049-3848(96)00146-6.
6
Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.凝血因子VIII/血管性血友病因子复合物对凝血因子V莱顿突变杂合子携带者活化蛋白C抵抗表型及静脉血栓栓塞风险的影响。
Blood Coagul Fibrinolysis. 1999 Oct;10(7):409-16.
7
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.由于一种先前未被认识的机制导致的家族性血栓形成倾向,其特征为对活化蛋白C的抗凝反应不佳:活化蛋白C辅因子的预测。
Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1004-8. doi: 10.1073/pnas.90.3.1004.
8
Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C.
Blood Coagul Fibrinolysis. 2000 Mar;11(2):175-82.
9
Resistance to activated protein C as a basis for venous thrombosis.对活化蛋白C的抵抗作为静脉血栓形成的基础。
N Engl J Med. 1994 Feb 24;330(8):517-22. doi: 10.1056/NEJM199402243300801.
10
A chromogenic assay for activated protein C resistance.活化蛋白C抵抗的显色测定法。
Br J Haematol. 1995 Aug;90(4):884-91. doi: 10.1111/j.1365-2141.1995.tb05210.x.

引用本文的文献

1
Effective INR Level May Be Delayed in Secondary Prevention of Stroke Due to Atrial Fibrillation with Warfarin in the Patients with Diabetes Mellitus.在糖尿病患者中,使用华法林进行心房颤动二级预防时,有效国际标准化比值(INR)水平可能会延迟出现。
Noro Psikiyatr Ars. 2018 Oct 24;56(4):273-276. doi: 10.29399/npa.23395. eCollection 2019 Dec.
2
Central venous catheter thrombosis complicated by paradoxical embolism in a patient with diabetic ketoacidosis and respiratory failure.一名患有糖尿病酮症酸中毒和呼吸衰竭的患者发生中心静脉导管血栓形成并伴有反常栓塞。
Neurocrit Care. 2005;2(2):185-8. doi: 10.1385/NCC:2:2:185.
3
An examination of the association between therapeutic anticoagulation control and glycemic control for patients with diabetes on oral anticoagulation therapy.
对接受口服抗凝治疗的糖尿病患者的治疗性抗凝控制与血糖控制之间关联的研究。
J Thromb Thrombolysis. 2005 Jun;19(3):209-12. doi: 10.1007/s11239-005-1715-9.
4
Urinary albumin excretion is correlated to fibrinogen levels and protein S activity in patients with type 1 diabetes mellitus without overt diabetic nephropathy.在无明显糖尿病肾病的1型糖尿病患者中,尿白蛋白排泄与纤维蛋白原水平及蛋白S活性相关。
Wien Klin Wochenschr. 2004 Apr 30;116(7-8):240-5. doi: 10.1007/BF03041054.